| Ms Eleanor Leinani Sharsh, LMHC | |
|
98-450 Koauka Loop Apt 206, Aiea, HI 96701-4519 | |
| (808) 779-4241 | |
| Not Available |
| Full Name | Ms Eleanor Leinani Sharsh |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 98-450 Koauka Loop Apt 206, Aiea, Hawaii |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205053303 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | LMHC-126 (Hawaii) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Eleanor Leinani Sharsh, LMHC 98-450 Koauka Loop Apt 206, Aiea, HI 96701-4519 Ph: (808) 779-4241 | Ms Eleanor Leinani Sharsh, LMHC 98-450 Koauka Loop Apt 206, Aiea, HI 96701-4519 Ph: (808) 779-4241 |
News Archive
New York Times contributing writer Tina Rosen, on the newspaper's "Opinionator" blog, examines the success of a system known as kangaroo care, which has helped to improve the survival rates of premature infants by using skin-to-skin contact with mothers in place of incubators in low-resource settings. The post notes the potential value of such a strategy in poor countries "where pregnant women are unlikely to get the food and care they need," and "low birth weight babies are very common."
The Johns Hopkins University (JHU) has entered into a drug-discovery research collaboration with Eisai, a pharmaceutical company based in Tokyo, to develop proprietary small-molecule drugs for a range of brain conditions such as schizophrenia, pain, brain tumors and Alzheimer's disease.
A variety of medications can help reduce the core symptoms of post-traumatic stress disorder (PTSD) as well as reduce associated depression and disability, but selective serotonin reuptake inhibitors (SSRIs) should be considered as first line agents as there is most evidence showing that these can be effective.
Grifols, a global healthcare company and biopharmaceutical manufacturer based in Barcelona, Spain today announced that it received approval from the US Food and Drug Administration for revised labeling for Alphanate Antihemophilic Factor/von Willebrand Factor Complex indicating that certain manufacturing steps have been shown to reduce the infectivity of a experimental TSE agent that is a model for variant Creutzfeldt Jakob Disease.
› Verified 5 days ago
Aileen T Playter, Counselor Medicare: Not Enrolled in Medicare Practice Location: 99-149 Moanalua Rd Ste 201, Aiea, HI 96701 Phone: 808-344-1130 Fax: 808-475-0295 | |
Dr. Nozanin Yusufovna Yusufbekova, PSYD Counselor Medicare: Not Enrolled in Medicare Practice Location: 99-128 Aiea Heights Dr Ste 704, Aiea, HI 96701 Phone: 808-425-2625 | |
Victoria Victorovna Sharov, LMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 99-015 Kalaloa St Apt 906, Aiea, HI 96701 Phone: 808-478-9143 | |
Miki Takushi, LMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 98-535 Lulu St, Aiea, HI 96701 Phone: 808-721-3544 | |
Dr. Angelica A. Tagaban, PSY.D., LMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 98-030 Hekaha St Ste 24, Aiea, HI 96701 Phone: 808-729-4913 | |
Mr. Edmund Nourrie Jr., LMHC Counselor Medicare: Medicare Enrolled Practice Location: 99-080 Kauhale St Ste C20, Aiea, HI 96701 Phone: 808-953-4682 |